Bio India Bio Combination 17 (450g) : Relieves Piles, Pain, Bleeding, Fissures, Backache

77

Bio India Bio Combination 17

BC 17- Piles

Composition of Bio India Bio Combination 17

  • Fluorica Calcarea 3x
  • phosphoric acid ferrum 3x
  • 3-fold Kalium Phosphoricum
  • three times the recommended dosage of kalium muriaticum

Indications of Bio India Bio Combination 17

  • Fissures, backaches, and hemorrhoids that are bleeding are all helped by it.
  • internal swelling and back pain
  • pimples on the outside that hurt like hell
  • painless or painful bleeding piles.

Action of Biochemic medicine in Bio India Bio Combination 17

Calcarea fluorica 3x Bearing down pain, varicose veins, Fissure of the anus, and intensely sore crack near the lower end of the bowel. Bleeding hemorrhoids, Internal or blind piles frequently, with pain in back, generally far down on the sacrum.: Bleeding hemorrhoids, Internal or blind piles frequently, with back pain that is typically located far down on the sacrum. Calcarea fluorica 3x Bearing down pain, varicose veins, fissure of the anus, and intensely painful crack near the lower end of the bowel.

Ferrum phosphoricum 3x Hemorrhoids, Incontinence, hemorrhage and congestion with heat and redness.: Hemorrhoids, Incontinence, Hemorrhage, Congestion with Heat and Redness, Ferrum Phosphoric 3x.

Kalium phosphoricum 3x Localised inflammation. Pain at anal region sudden, sharp, tearing externally.: Pain at the anal region that is sudden, sharp, and tearing outward can be treated with kalium phosphoricum three times.

Kalium muriaticum 3x Hemorrhoids; bleeding, blood dark and thick, fibrinous, clotted.: Hemorrhoids; bleeding; dark, thick, fibrous, clotted blood; Kalium muriaticum 3x

Dosage of Bio India Bio Combination 17

Four tablets per day for adults, or four times every three hours.

Kids: 1–2 tablets, 4 times daily.

Attributes
BrandBio-India Pharma
Container TypeGlass Bottle
Shelf Life5 Years
Remedy TypeHomeopathic
Country of OriginIndia
Homeo FormsBiocombination Tablet
Price₹ 630

Comments are closed.